We localized the chemotherapeutic drug daunomycin inside cultured cells by taking advantage of its inherent fluorescence. Multidrug-resistant cultured cells, in which the accumulation of daunomycin can be reversibly controlled with vera@ to black the multidrug transporter, were incubated in daunomycin and verapamil and the accumulated daunomycin was visualized with epifluorescwce optics. After fuation under a variety of different conditions to make cells permeable to diaminobenzidine (DAB), the internal daunomycin was illuminated under the fluorescence miaoscope in the presence of DAB. Photooxidation of DAB in sites of fluorescing daunomycin (photoconversion) d t e d in intracellular deposition of oxidized DAB product. These sites were then visualized by transmission electron microscopy.
Introduction
Fluorescence photoconversion is a method in which a fluorescing compound can cause photooxidation (photoconversion) of adjacent compounds. If these adjacent compounds, such as diaminobentidine (DAB), become precipitated and electron dense on oxidation, then this process can yield an ultrastructural cytochemically detectable deposit in the immediate vicinity of the fluorescing material. This approach has been used previously to demonstrate the location of cytochemical fluorescent exogenous markers, such as Lucifer yellow (1) or fluorescein and other biologically active molecules (2,3). For these studies we used this novel approach to identrfy the location of a clinically important antineoplastic chemotherapeutic drug, daunomycin (daunorubicin).
Daunomycin is an inherently fluorescent compound, yielding
Correspondence and current address: Dr. M. C. Willingham, Dept. of Pathology and Laboratory Medicine, Medical U. of South Carolina, 171 Ashley Ave., Charleston, SC 29425-0687. apparent quenching of the nuclear fluorescence but still allowed fluorescence to m r in other cell organelles, which were then well preserved. Daunomycin was found in the nuclear envelope, the endoplasmic reticulum, and in lysosomes in cells in which the multidrug transporter was inhibited. Lysosomal accumulation has been previously described and was expected because of the known accumulation of positively charged molecules in organelles with low pH. However, the accumulation of daunomycin in the nudear envelope and endoplasmic reticulum has not. been previously observed. These results clearly demonstrate the utility of fluorescence photoconversion methodology for the highresolution ultmtmctural localization of fluorescent materials. (J Hstochem Cytochem 41:1573 -1577 , 1993 red fluorescence emission when exposed to green light, the absorption/emission combination characteristic of "rhodamine" fdters used in epifluorescence microscopes. Daunomycin and its structurally related anthracycline, adriamycin (doxorubicin), concentrate within the nucleus in living cells, the site at which the drug is thought to bind to DNA and interfere with cell multiplication, hence its use as an antineoplastic agent (4-6). Since daunomycin contains an amino group that is positively charged at physiological pH, it has also been seen in living cells accumulated in structures that were consistent in their size, shape, and distribution with lysosomes (6). Other sites of daunomycin accumulation, however, have not been clearly delineated owing to the low resolution of light microscopic techniques (4-7).
Multidrug resistance (MDR) is the property of some tumor cells to show cross-resistance to multiple drugs of diverse chemical structure (8-10). One major cause of such resistance is the presence of an ATP-dependent pump in the plasma membrane of multidrugresistant cells, a protein termed P-glycoprotein or "the multidrug transporter" (8-10). This pump prevents a variety of drugs from accumulating in the cytoplasm, including anthracyclines such as daunomycin (6,ll). The activity of this multidrug transporter can be blocked by reversing agents that bind to the transporter with high affinity, such as verapamil or quinidine. The human MDRl gene which encodes the human multidrug transporter has been isolated and introduced into a mouse fibroblast cell line, NIH3T3, to yield a multidrug-resistant line termed NIH3T3-MDR (7). This cell line, normally propagated in high concentrations of MDR drugs such as colchicine, is highly resistant to daunomycin and other drugs affected by the MDR resistance phenotype. Normally, daunomycin fails to accumulate in such cells because of the efflux activity of this multidrug transporter in the plasma membrane. In the presence of verapamil, however, the transporter can be blocked and daunomycin accumulates in these cells in a manner similar to that in normal drug-sensitive cells (6).
We used this NIH3T3-MDR cell line to examine the ultrastructural accumulation of daunomycin with the fluorescence photoconversion approach. The results of these experiments show low accumulation of daunomycin in resistant cells and the expected localization of daunomycin in nuclei and in lysosomes in cells in which the multidrug transporter was inhibited by verapamil. In addition, a previously undetected accumulation of this drug in the nuclear envelope and endoplasmic reticulum was also observed.
Materials and Methods

Cells. NIH3T3-MDR cells, NIH3T3 mouse cells into which the human
MDRl gene carrying a glycine to valine mutation at position 185 had been transfected, were derived and propagated as described elsewhere (7). These cells were maintained under selection in Dulbecco's modified Eagle's medium with 10% calfserum (GibcolBW, Gaithersburg, MD), penicillin (50 Ulml), streptomycin (50 pglml), and colchicine (1 pglml) (GibcolBRL.). Cells were grown on 35-mm plastic tissue-culture dishes in a 95% airl5% CO2 atmosphere and used 48 hr after plating.
Experimental IncubaUons. NIH3T3-MDR cells in 35-mm culture dishes were incubated in regular medium with or without verapamil (Sigma; St Louis, MO) at a concentration of 10 pglml for 15 min at 37°C in a humidified aidCO2 incubator. Daunomycin (Sigma) in aqueous stock solution at 1 mglml was then added to the cells to a final concentration of 5 pglml for 60 min at 37'C.
FIuorescence Microscopy. For observations of living cells, the cells were washed in Dulbecco's PBS containing Cat+ and Mg" at 23°C and then daunomycin (5 pglml) was added with or without verapamil, followed by washing in regular mediumwith wrapamil. For observations of fixed cells, the dishes were washed with PBS (with Ca" and Mg") after daunomycin incubations and then fixed in 3.7% formaldehyde in PBS for 10 min at 23'C. Other dishes were fixed in glutaraldehyde at various concentrations from 0.1% to 3% in PBS. The optimal concentration for electron microscopic preservation and detection of daunomycin by photoconversion in cytoplasmic structures was 0.25%. Living cells were examined with a Zeiss RA microscope equipped with epifluorescence optics with a Plan-Neofluar x 25, NA 0.8 water-immersion objective. Photographs were made with Kodak Tri-X film developed in Diafine. Fixed cells were examined and photographed with a x 40, NA 1.0 planapochromat oil-immersion objective.
Electron Microscopy and Photoconversion. NIH3T3-MDR cells in 35mm culture dishes were incubated with daunomycin, with or without verapamil, washed quickly with PBS, and immediately fixed in 3.7% formaldehyde in PBS or glutaraldehyde (0.14%) in PBS. After washing with PBS, the dishes were treated with sodium borohydride (Sigma) at 0.5 mglml in PBS for 2 min at 23'C. The cells were washed in PBS and an area was selected by scraping away unwanted cells with a wooden applicator stick, leaving a focus of cells for photoconversion. These cells were then incubated with 0.5 mglml DAB in PBS for 12 min at 23'C. followed by addition of fresh DAB when the cell focus was illuminated under a x 25 NA 0.8 Neofluar water-immersion objective. The accumulated daunomycin in the cells was visualized with rhodamine epifluorescence filters (excitation 546 nm, emission >590 nm) and the cells were exposed to the excitation green light for a period of 15-30 min or until no residual fluorescence signal was detected. This was followed by several washes in PBS and fixation in 2.5% glutaraldehyde in PBS. The cells were then post-fixed in 1% Os04 in water. After ethanol dehydration and embedding in Epon 812 in situ, the selected illuminated area was sectioned and the thin sections were counterstained with 1% aqueous uranyl acetate and lead citrate. The sections were viewed with a Philips 400T electron microscope at 40 kV.
Localization of Daunomycin in Formalde by de-fixed Cells
It has been shown that when living drug-sensitive cells are incubated with daunomycin, light microscopic fluorescence microscopy shows the presence of drug in the interior of the nucleus, in lysosomes, and in other intracytoplasmic vesicular organelles (4-7). Although a few details inside the nucleus can be seen in these preparations, the resolution of these methods does not allow a clear image of the nuclear envelope or identification of other cytoplasmic vesicular structures, beyond the identification of lysosomes (6). When such cells are fixed in formaldehyde much of the cytoplasmic localization is lost, but the localization within the nucleus is retained (6).
Fluorescence (A, B) and phase-contrast (A, B ) images of cells incubated with daunomycin, then fixed in formaldehyde, are shown in Figure 1 . When drugresistant NIH3T3 cells were incubated with the drug, the multidrug transporter prevented the accumulation of the drug in the cell and, after formaldehyde fixation, no signal was seen in the nuclei (Figure 1A) . When the cells were also treated with verapamil, which blocks the activity of the multidrug transporter, the cells accumulated daunomycin in the nucleus similar to that seen in normal drug-sensitive cells (Figure 1B) . When these cells were then processed for fluorescence photoconversion with light exposure in the presence of DAB, the daunomycin fluorescence in the fixed nuclei caused a strong accumulation of oxidized DAB, indicating an intranuclear accumulation that was visible by electron microscopy (Figure IC) . Preservation of the structural details in the cytoplasm, however, is not sufficient in such a preparation to provide much information about the cytoplasmic distribution of the drug.
Localization of Daunomycin in Glutaraldehyde-fixed Cells
When cells were incubated with daunomycin, then fixed with glutaraldehyde, a fluorescence pattem different from that seen with formaldehyde fiition was detected . Figures 2A and 2B show fluorescence images of multidrug-resistant cells treated (B) with or (A) without verapamil, in which the fluorescence image shows a large amount of autofluorescence (A) in cells that show very little daunomycin accumulation if examined in the living state, and a slight increase in fluorescence in cells that have accumulations of intracellular daunomycin (B). Much of the autofluorescent signal was present in mitochondria. This autofluorescence makes it very difficult to see clearly the fluorescence signal specific for daunomycin. The autofluorescence signal rapidly bleaches when exposed to the excitation light, but some of the daunomycin-specific signal also is bleached under these conditions. Indeed, the amount of fluorescence seen in the nuclei in NIH3T3-MDR cells exposed to verapamil is dramatically diminished compared with living cells or formaldehyde-fmed cells. This suggests that the tight cross-linking of the glutaraldehyde fmtive may prevent nuclear daunomycin from fluorescing owing to local quenching effects.
When verapamil-treated NIH3T3-MDR cells were processed by photoconversion in the presence of DAB, the images shown in Figure 3 were seen by electron microscopy. The nuclei showed very little intranuclear signal, as expected from the fluorescence results. High concentrations of glutaraldehyde (2-3%) increased autofluorescence and decreased specific fluorescence, whereas low concentrations (0.1%) showed poor morphological preservation. The optimal concentration found in this study to preserve both some fluorescence and reasonable morphology was 0.25%. Lysosomes showed large accumulations of oxidized DAB product and there were also strong DAB deposits in the endoplasmic reticulum and the nuclear envelope. In addition, some small elongated tubules in the Golgi region showed accumulations of oxidized product. Mitochondria showed no DAB product, perhaps due to the rapid bleaching of their autofluorescence signal or because the autofluorescing sites do not produce photoconversion of DAB as efficiently as fluorescing daunomycin. In cells with very low levels of daunomycin accumulation (cells not treated with verapamil) there was very little detectable signal at the EM level in any of these structures (results not shown). This suggests that the localization of DAB product shown in Figure 3 is specific for sites of daunomycin accumulation.
Discussion
It has been previously shown that the chemotherapeutic drug daunomycin accumulates in cells that are drug sensitive but fails to accumulate in large amounts in cells that have an active multidrug transporter (6.11). The location of daunomycin in drugsensitive cells or in resistant cells that have been treated with transporter blockers, such as vcrapa.mil. has been demonstrated by light microscopy, but a detailed evaluation of organelle location has been difficult because of the limited resolution of fluorescence techniques. Fluorescence photoconversion, in which photooxidation of fluorescing materials has been exploited to oxidize electron-dense substrates such as DAB, has been previously described for detection of Lucifer yellow, fluorescein, and some other fluorescent molecules (14.12). In this work we combined study of the localization of daunomycin with the fluorescence photoconversion method to evaluate the location of the drug in cells by electron microscopy. The fluorescence properties of daunomycin provide a unique opportunity to study the location of a low molecular weight, chemotherapeutically active drug in situ.
We observed that glutaraldehyde fixation rendered nuclear daunomycin unable to fluoresce, yielding no EM-detectable intranuclear signal. The environment of fluorescing materials can dramatically affect the ability of these molecules to fluoresce. Tight cross-linking of intracellular molecules by glutaraldehyde has been previously shown to impair diffusion of other molecules in the fued cell matrix (13). Therefore, it is not surprising that glutaraldehyde fixation might tender the nuclear contents sufficiently dense to inhibit the fluorescence of nuclear daunomycin. Formaldehyde, on the other hand, is a relatively weak cross-linking fmtive, and renders fixed nuclei permeable to large molecules and leaves daunomycin in an environment that permits fluorescence. The poor preservation seen with formaldehyde, however, makes morphological interpretations in the cytoplasm much less clear.
A novel fmding in these results was the presence of large amounts of daunomycin in the nuclear envelope and the endoplasmic reticulum in cells in which the multidrug transporter had been inhibited.
EM provides improved resolution and the ability to see these unexpected sites of localization clearly. In addition, we also found the expected concentrations of daunomycin in lysosomes and in small tubular elements of the trans-Golgi system. Accumulation in these structures is to be expected because of the titratable amino group on daunomycin that causes it to accumulate in vesicular structures with a low pH, a property already shown for other compounds with other methods (14). However, other organelles known to be acidic, such as endosomes, showed little or no accumulation of daunomycin. It is possible that parts of the endoplasmic reticulum also have a pH sufficiently low to cause accumulation of this drug, but it is also possible that other properties of these membrane elements favor daunomycin accumulation. Although most of the pharmacological effects of daunomycin may depend on localization in the nucleus, some of its effects on cells may be due to its association with the endoplasmic reticulum-nuclear envelope system. Similar EM studies with other compounds that accumulate in acidic compartments, but affect cells by other mechanisms, might help to clarify the significance of these results.
